NEXTCURE INC. - COMMO

NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting

04 Oct 2024 09:05:00 By Nasdaq GlobeNewswire

NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024

16 Sep 2024 08:05:00 By Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results

01 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

20 Jun 2024 16:10:00 By Nasdaq GlobeNewswire

NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024

30 May 2024 16:05:00 By Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports First Quarter 2024 Financial Results

02 May 2024 16:05:00 By Nasdaq GlobeNewswire

NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024

24 Apr 2024 16:05:00 By Nasdaq GlobeNewswire

NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024

08 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board

04 Apr 2024 07:05:00 By Nasdaq GlobeNewswire

NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference

02 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports Full Year 2023 Financial Results

21 Mar 2024 08:55:00 By Nasdaq GlobeNewswire

NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances

05 Mar 2024 08:05:00 By Nasdaq GlobeNewswire

NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders

18 Jan 2024 16:05:00 By Nasdaq GlobeNewswire

NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury

21 Dec 2023 07:05:00 By Nasdaq GlobeNewswire

NextCure Provides Year-End Clinical Pipeline Updates

14 Dec 2023 06:45:00 By Nasdaq GlobeNewswire

NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference

20 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525, a Novel LAIR-1 Antibody for AML

15 Nov 2023 16:05:00 By Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports Third Quarter 2023 Financial Results

02 Nov 2023 16:05:00 By Nasdaq GlobeNewswire

Preclinical Data Demonstrate Anti-Siglec-15 Treatment Reduced Bone Loss and Enhanced Bone Quality in Mice with Moderate-to-Severe Osteogenesis Imperfecta (OI)

17 Oct 2023 08:05:00 By Nasdaq GlobeNewswire

NextCure Presents Preclinical Data on NC181, a Novel Therapeutic Candidate Targeting ApoE4, for the Treatment of Alzheimer’s Disease

26 Sep 2023 16:05:00 By Nasdaq GlobeNewswire